Oncogramme responses of breast tumour cells treated with herceptin correlate with HER2/C-ERB B2 pathological status.

20124 citationsJournal Article

Authors

Abstract

Comparison between Herceptin responses obtained with Oncogramme and HER2 status of breast tumour cells confirmed that Oncogramme is a reliable method for prediction of patient cell sensitivity to anticancer drugs.

Topics & Keywords

HER2/EGFR in Cancer Research Monoclonal and Polyclonal Antibodies Research Advanced Biosensing Techniques and Applications

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: PubMed

Volume 32, Issue 4, pp. 1323-5

Field-Weighted Citation Impact: 0.00